Associated Papers
Eliglustat substrate reduction therapy in children with Gaucher disease type 1.
Ain NU et al.
Frontiers in Pediatrics, 2025
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center.
Basiri M et al.
Elife, 2023
Select a paper to view details